RSS   Newsletter   Contact   Advertise with us
Post Online Media

Biogen appoints Michel Vounatsos as CEO

Michel VounatsosBiogen, a biotechnology company, announced that it has appointed Michel Vounatsos as chief executive officer and member of the board of directors, effective January 6, 2017.

Mr. Vounatsos previously held the position of Executive Vice President and Chief Commercial Officer at Biogen.

READ MORE Biogen names EVP, pharmaceutical operations & technology

Mr. Vounatsos joined Biogen in April 2016 after a 20 year career at Merck.

While at Merck, he held leadership positions of increasing responsibility in Europe, China, and the U.S., driving significant and consistent growth across multiple geographies.

Mr. Vounatsos brings to the role of chief executive a background in both medicine and business.

He attended the Université Victor Segalen, Bordeaux II, in France, where he received his C.S.C.T. certificate in Medicine; subsequently, he graduated with an MBA from the HEC School of Management in Paris.

Mr. Vounatsos succeeds George A. Scangos, Ph.D., who has led the company since 2010 and had previously announced that he would step down once a successor was found.




What to read next



 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy